Automated Author ProfileXu, Yilun
First Affiliated Hospital of Wenzhou Medical University
Xu, Yilun
Current S-Index
Sum of Dataset Indices for all datasets
Average Dataset Index per Dataset
Average Dataset Index per dataset
Total Datasets
Total datasets for this author
Average FAIR Score
Average FAIR Score per dataset
Total Citations
Total citations to the author's datasets
Total Mentions
Total mentions of the author's datasets
S-Index Interpretation
The S-Index (Sharing Index) is a comprehensive metric that represents the cumulative impact of all your datasets. It is calculated as the sum of Dataset Index scores across all your claimed datasets.
What it means:
- A higher S-index indicates greater overall impact of your datasets relative to typical datasets in their fields of research
- The S-Index grows as you add more datasets or as existing datasets gain more citations and mentions
- It provides a single number to track your research data impact over time
Current S-Index: 4.2 (sum of 2 datasets Dataset Index scores)
More information here.
S-Index Over Time
Cumulative Citations Over Time
Cumulative Mentions Over Time
Datasets
Additional file 2: Fig. S1. Flow chart of the experimental design and main process. Fig. S2. Kaplan-Meier curves for GC patients stratified by lipid factors. (A) Kaplan-Meier analysis of Progression-free survival (PFS) of Cholesterol, Triglyceride, HDL and LDL;(B) Nomogram developed by integrating metabolic syndrome and clinical pathological parameters for predicting 1-, 3-, 5-year PFS survival of GC patients; (C) Calibration curve for risk of 1-, 3-, 5-year PFS survival of metabolic syndrome.
Authors
- Li, Yanyan ;
- Zhao, Jungang ;
- Chen, Renpin ;
- Chen, Shengwei ;
- Xu, Yilun ;
- Cai, Weiyang
Additional file 2: Fig. S1. Flow chart of the experimental design and main process. Fig. S2. Kaplan-Meier curves for GC patients stratified by lipid factors. (A) Kaplan-Meier analysis of Progression-free survival (PFS) of Cholesterol, Triglyceride, HDL and LDL;(B) Nomogram developed by integrating metabolic syndrome and clinical pathological parameters for predicting 1-, 3-, 5-year PFS survival of GC patients; (C) Calibration curve for risk of 1-, 3-, 5-year PFS survival of metabolic syndrome.
Authors
- Li, Yanyan ;
- Zhao, Jungang ;
- Chen, Renpin ;
- Chen, Shengwei ;
- Xu, Yilun ;
- Cai, Weiyang